BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP), an emerging pharmaceutical company developing prostone-based therapies for age-related and other diseases, today announced that a spring 2007 survey of U.S. nursing home pharmacy providers by Verispan ranks Sucampo Pharmaceuticals as a top 20 pharmaceutical company in a number of categories relating to promotional activities.
